Grant: Discovery Grants Program - Individual
Université Laval
$42,000.00
Methods to study the long-term effects of nanoparticles in vivo
EF 2023-24
Résumé
Because nanomedicines are new technologies, understanding their interactions with biological systems requires the development of adapted methodologies. These new analytical approaches enable better understanding of the factors governing the properties and functions of nanomaterials, and facilitate the engineering of improved technologies. In the last years, our laboratory has gained leadership in establishing methods to track and monitor the fate of nanomedicines in biological environments, notably in cell culture and in vivo. Specifically, we have developed Size Exclusion of Radioactive Polymers (SERP) as a new method to monitor the degradation of polymers. By combining the specificity of radiolabeling with the ability of size exclusion to separate large colloids from smaller molecules, the method is compatible with analysis in simple solutions, as well as complex biological matrices. This fundamental work has led to the identification of one research areas that could benefit from further development of the SERP method: understanding the biodegradation of nanomaterials. The first part of this research program will therefore expand on the SERP method to evaluate how the physicochemical properties of nanomaterials affect their degradation during storage, but also after in vivo administration. Specifically, using libraries of nanoparticles, we will evaluate how properties like size, surface functionalization and material composition affect the properties of nanoparticles as drug carriers. To highlight the potential of the SERP method further, we will show how this information can be used to predict and monitor the long-term fate of nanoparticles in vivo. In parallel to SERP, we have developed flow cytometry and biodistribution methods that increase our understanding of the interactions of nanomaterials with cells. This has allowed studying how immune proteins dictate the interactions of nanomaterials with living organisms; these findings have implications for the pharmacology and toxicology of nanomedicines. In this research program, we will develop new methods to monitor how interactions with nanoparticles can affect the biological functions of cells. Specifically, we will develop and characterize a labelling method to monitor how cell proliferate after exposure being exposed to nanoparticles. In brief, this multidisciplinary program will exploit elements of chemistry, radiolabeling, physical chemistry, nanotechnology and biology to offer a better understanding of how to engineer nanoparticles that can safely be used in medicine. This program will advance the field of analytical nanotechnology, functional materials, pharmaceutical sciences and nanomedicine, but also fundamental biology and immunology.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2023-05349
Name nom
Bertrand, Nicolas
Department département
Pharmacy
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2023
Award amount
42000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
6404
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Pharmacology
Research subject en
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject fr
Pharmacologie
Application title
Methods to study the long-term effects of nanoparticles in vivo
Keyword
Cell labelling; Chromatography; Fluorescence; Nanomedicines; Nanoparticles; Polymer chemistry; Radiolabeling
Application summary
Because nanomedicines are new technologies, understanding their interactions with biological systems requires the development of adapted methodologies. These new analytical approaches enable better understanding of the factors governing the properties and functions of nanomaterials, and facilitate the engineering of improved technologies. In the last years, our laboratory has gained leadership in establishing methods to track and monitor the fate of nanomedicines in biological environments, notably in cell culture and in vivo. Specifically, we have developed Size Exclusion of Radioactive Polymers (SERP) as a new method to monitor the degradation of polymers. By combining the specificity of radiolabeling with the ability of size exclusion to separate large colloids from smaller molecules, the method is compatible with analysis in simple solutions, as well as complex biological matrices. This fundamental work has led to the identification of one research areas that could benefit from further development of the SERP method: understanding the biodegradation of nanomaterials. The first part of this research program will therefore expand on the SERP method to evaluate how the physicochemical properties of nanomaterials affect their degradation during storage, but also after in vivo administration. Specifically, using libraries of nanoparticles, we will evaluate how properties like size, surface functionalization and material composition affect the properties of nanoparticles as drug carriers. To highlight the potential of the SERP method further, we will show how this information can be used to predict and monitor the long-term fate of nanoparticles in vivo. In parallel to SERP, we have developed flow cytometry and biodistribution methods that increase our understanding of the interactions of nanomaterials with cells. This has allowed studying how immune proteins dictate the interactions of nanomaterials with living organisms; these findings have implications for the pharmacology and toxicology of nanomedicines. In this research program, we will develop new methods to monitor how interactions with nanoparticles can affect the biological functions of cells. Specifically, we will develop and characterize a labelling method to monitor how cell proliferate after exposure being exposed to nanoparticles. In brief, this multidisciplinary program will exploit elements of chemistry, radiolabeling, physical chemistry, nanotechnology and biology to offer a better understanding of how to engineer nanoparticles that can safely be used in medicine. This program will advance the field of analytical nanotechnology, functional materials, pharmaceutical sciences and nanomedicine, but also fundamental biology and immunology.